Business 20 leaders to make sweeping recommendations to improve global healthcare.
Strong Financial Performance on Continued Procedure Volume Recovery and Share Gains from New Product Launches
As a result, Medtronic receives highest U.S. honor for support of Guard and Reserve employees.
Medtronic plc (NYSE:MDT), the global leader in medical technology, today received U.S. Food and Drug Administration (FDA) 510(K) clearance on the first and only...
Medtronic has analyzed iPhone technology and found that it presents no increased risk of interference with Medtronic implantable cardiac rhythm devices, such as pacemakers, implantable...
Medtronic’s fourth quarter results reflect a strong recovery from the impact of the COVID-19 pandemic on elective procedures that the company experienced in April 2020.
Here are the top five things Medtronic learned from the pandemic and why we won’t forget.
February 23 – Earlier today, Medtronic reported third quarter 2021 financial results. This infographic provides key highlights. For more information, view our press release or visit...
Temporary Limited Modifications to Bio-Medicus Adult Cannulae and Introducers, Bio-Medicus Cannulae Kits, & Bio-Medicus Pediatric Cannulae and Introducers Indications to Support Longer Duration Use in ECMO Therapy to Address COVID-19
Company ranks among top five in industry.